<DOC>
	<DOCNO>NCT02996487</DOCNO>
	<brief_summary>The goal study evaluate whether use vancomycin orally prevent CDI patient colonize C. diff admit hospital need antibiotic another infection .</brief_summary>
	<brief_title>Screening Prophylax Against Clostridium Difficile Infection -</brief_title>
	<detailed_description>Screening Prophylax CDI ( SToP CDI ) prospective , single-center , double-blinded , randomize , placebo-controlled study effectiveness vancomycin vs. placebo prevent CDI patient colonize toxigenic C. difficile receive high-risk antibiotic . The investigator plan screen 2500 patient randomize 200 . Consented patient stool sample collect tested presence toxigenic C. difficile PCR . Patients test negative simply follow development , severity outcome CDI . Patients test positive ( colonized C. difficile ) randomize one two arm : Arm 1 : Patients receive 125 mg vancomycin PO q6 hour prophylaxis C. difficile duration antibiotic treatment +3 day . Arm 2 : Patients receive placebo PO q6 hour duration antibiotic treatment +3 day .</detailed_description>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<criteria>1 . Expected duration admission least 48 hour enrollment study 2 . Age â‰¥18 3 . Able give inform consent 4 . Initiated one follow antibiotic within prior 72 hour expect duration least 72 hour enrollment : clindamycin , ampicillin , ampicillin/sulbactam , amoxicillin , amoxicillin/clavulanate , moxifloxacin , levofloxacin , piperacillin/tazobactam , cephalosporin 5 . Maximum expected duration antibiotic 14 day 6 . Able take oral study medication 7 . Able provide stool sample 8 . Reasonably expect able complete follow 1 . Chron 's disease , ulcerative colitis , celiac disease , chronic diarrheal illness 2 . CDI within prior 90 day 3 . Immunosuppressed include uncontrolled AIDS , immunosuppressive medication , transplant 4 . Currently metronidazole , oral vancomycin , rifaximin , fidaxomicin , antibiotic active C. difficile 5 . Current diarrhea 6 . Active malignancy ( except basal cell carcinoma ) 7 . Current ileostomy , colostomy form surgically disconnect gut oral therapy would expect reach entire lumen gut 8 . Pregnancy breast feeding ( determine prior randomization ) 9 . Recent ( within 60 day ) pending chemotherapy 10 . Travel area endemic diarrheal illness within last 30 day 11 . Life expectancy le 60 day 12 . Known allergy vancomycin 13 . Prior antibiotic within last 60 day 14 . Participation research trial could impact result trial within last 30 day 15 . Previously enrol study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>